Tag Archives: RituxME

Research: Endothelial dysfunction in ME/CFS

Posted on 02/08/2023 by wames

Endothelial dysfunction and vascular homestasis in ME/CFS   A sub-study of the RituxME trial by Norwegian researchers found a problem in the blood vessels on the heart in a group of people with ME/CFS. Treatment with Rituximab caused a slight … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Research: Endothelial dysfunction in ME/CFS

Left out – a Norwegian documentary about ME & research

Posted on 02/02/2020 by wames

Left out – a documentary about ME The documentary Left Out (De Bortgjemte) was shown on national TV in Norway in 2018 and now has its international release on YouTube with English subtitles, 29 January 2020. Director Paul Schaathun followed … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on Left out – a Norwegian documentary about ME & research

Norwegian Rituximab studies update

Posted on 11/03/2017 by wames

Helse Bergen blog post, 29 Sep 29017: RituxME B-lymphocyte depletion using the anti-CD20 antibody rituximab (Mabthera®) in Myalgic Encephalopathy/Chronic Fatigue Syndrome (“RituxME”) ​RituxME is a multicentre study conducted in five study centres in Norway: the Oncology Department at Haukeland University … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on Norwegian Rituximab studies update